Qingdao NovelBeam Technology Co.,Ltd.

XSSC:688677 Stock Report

Market Cap: CN¥4.4b

Qingdao NovelBeam TechnologyLtd Past Earnings Performance

Past criteria checks 2/6

Qingdao NovelBeam TechnologyLtd has been growing earnings at an average annual rate of 12.9%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 15.6% per year. Qingdao NovelBeam TechnologyLtd's return on equity is 9.6%, and it has net margins of 30.2%.

Key information

12.9%

Earnings growth rate

7.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate15.6%
Return on equity9.6%
Net Margin30.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Qingdao NovelBeam TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:688677 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244131257359
30 Jun 244231277262
31 Mar 244401366864
31 Dec 234711466966
30 Sep 235131616873
30 Jun 235481926570
31 Mar 235321956366
31 Dec 224771835860
30 Sep 224311665055
30 Jun 223701394649
31 Mar 223361274545
31 Dec 213101184341
30 Sep 212941134039
30 Jun 212761053635
31 Mar 21271923534
31 Dec 20275963231
30 Sep 20259893428
31 Dec 19253723329
31 Dec 18201552722
30 Jun 181663939-4
31 Mar 1817648390
31 Dec 17181512316
30 Sep 1716948370
30 Jun 17159462112
31 Dec 1613933380
30 Sep 1612930370
30 Jun 1611927360
31 Mar 169721290
31 Dec 157416210
31 Dec 14687180
31 Dec 1352-1170

Quality Earnings: 688677 has high quality earnings.

Growing Profit Margin: 688677's current net profit margins (30.2%) are lower than last year (31.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688677's earnings have grown by 12.9% per year over the past 5 years.

Accelerating Growth: 688677's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688677 had negative earnings growth (-22.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 688677's Return on Equity (9.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 08:14
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Qingdao NovelBeam Technology Co.,Ltd. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.
Zhu ChenCitic Securities Co., Ltd.